当前位置: 首页 > 期刊 > 《现代泌尿外科杂志》 > 2007年第3期
编号:11417678
多沙唑嗪控释片在嗜铬细胞瘤术前准备应用的初步报告
http://www.100md.com 《现代泌尿外科杂志》 2007年第3期
嗜铬细胞瘤;α1受体阻滞剂;安全性,,嗜铬细胞瘤;α1受体阻滞剂;安全性,1资料与方法,2结果,3讨论,参考文献:
     Cardura: a newly selective α1 inhibitor (controlled release tablets) in the management of patients with pheochromocytoma

    Zhu Yu, Wang Weiqing, Wu Yuxuan, Zhang Congyu, Rui Wenbin, Zhou Wenlong, Sun Fukang, Liu Dingyi, Shao Yuan, Shen Zhoujun, Bi Yufang, Su Tingwei, Jiang Lei, Ning Guang

    (Department of Urology; Department of Endocrinology, Ruijin Hospital, the Affiliated Hospital of Shanghai Jiaotong University Medical School, Shanghai 200025, China)

    ABSTRACT: Objective To elevate the perioperative security of pheochromocytoma cases. Methods 65 cases received selective α1 receptor blocker doxazosin (Controlled Release Tablets, Cardura) to control their hypertension before operation. Results Two patients with persistent hypertension needed calcium ion antagonist combined with ACEI, the others got a satisfied blood pressure level with Cardura. Conclusion Cardura could reduce medicine untoward reaction obviously.

    KEY WORDS: pheochromocytoma; selective α1 receptor blocker; security

    摘要:目的 提高嗜铬细胞瘤患者围手术期治疗的安全性 ......

您现在查看是摘要页,全文长 7324 字符